HBM Holdings Limited (HKG:2142)
Hong Kong · Delayed Price · Currency is HKD 11.06
+0.32 (2.98%)
Nov 10, 2026, 4:08 PM HKT
HBM Holdings Market Cap
HBM Holdings has a market cap or net worth of 9.13 billion as of November 9, 2026. It is the 9,195th most valuable company in the world and the 458th biggest in Hong Kong. Its market cap has decreased by 16.50% in one year.
Market Cap
9.13B
Enterprise Value
7.02B
Revenue
1.40B
Global Rank
Country Rank
#458 Hong Kong
PE Ratio
13.76
ChartMarket Cap Chart
Since December 10, 2020, HBM Holdings's market cap has increased from 8.46B to 9.13B, an increase of 7.91%. That is a compound annual growth rate of 1.29%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 10, 2026 | 9.13B | -10.18% |
| Dec 31, 2025 | 10.17B | 646.15% |
| Dec 31, 2024 | 1.36B | -3.91% |
| Dec 29, 2023 | 1.42B | -32.16% |
| Dec 30, 2022 | 2.09B | -63.14% |
| Dec 31, 2021 | 5.67B | -30.06% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 10, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Ascentage Pharma Group International | 10.77B |
| Everest Medicines | 9.50B |
| Duality Biotherapeutics | 9.50B |
| CStone Pharmaceuticals | 8.51B |
| GenFleet Therapeutics (Shanghai) | 8.07B |
| Suzhou Ribo Life Science | 7.33B |
| Shanghai Haohai Biological Technology | 7.26B |
| Nanjing Leads Biolabs | 7.13B |